You're reading the free version. Trader adds the live tape and alerts.
Start tracking
URGN Sale Disclosure
Degnan Chris · SEC Form 4 · Filed Oct 9, 2026
Sale
Calculated transaction value
$80.79K
Degnan Chris Chief Financial Officer
URGN
UroGen Pharma Ltd
URGN
Transaction date
Oct 8, 2026
Public filing date
Oct 9, 2026
Filing lag
Filed 1 day later
URGN daily price context
Close on/before transaction
$36.98
Oct 8, 2026
First close after public filing
$36.83
Oct 9, 2026
30-day return after filing
-28.56%
Through Nov 9, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Ordinary Shares
- Quantity / price
- 2,202 shares @ $36.69
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001437749-26-032421
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$80.79K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Urogen Pharma Ltd. URGN Current | Sale | Oct 8, 2026 | $80.79K |
| Urogen Pharma Ltd. URGN | Exercise | Oct 8, 2026 | $0 |
| Urogen Pharma Ltd. URGN | Exercise | Oct 8, 2026 | Not reported |